Publications by authors named "Caitlin Stashwick"

Claim this Profile
O
Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers.
Mark H O'Hara, Caitlin Stashwick, Gabriela Plesa, Janos L Tanyi

Immunotherapy· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells.
Janos L Tanyi, Caitlin Stashwick, Gabriela Plesa, Mark A Morgan, David Porter

J Immunother· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy.
Mark O'Hara, Caitlin Stashwick, Andrew R Haas, Janos L Tanyi

Immunotherapy· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy.
Jenessa B Smith, Evripidis Lanitis, Denarda Dangaj, Elizabeth Buza, Mathilde Poussin, Caitlin Stashwick

Mol Ther· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race-based disparities in loss of functional independence after hysterectomy for uterine cancer.
Lorraine T Dean, Xiaochen Zhang, Nawar Latif, Robert Giuntoli, Lilie Lin, Caitlin Stashwick

Support Care Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer.
Katarzyna Urbanska, Caitlin Stashwick, Mathilde Poussin, Daniel J Powell

Cancer Immunol Res· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells.
Katarzyna Urbanska, Rachel C Lynn, Caitlin Stashwick, Archana Thakur, Lawrence G Lum

J Transl Med· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B7-H4 as a potential target for immunotherapy for gynecologic cancers: a closer look.
Jenessa B Smith, Caitlin Stashwick, Daniel J Powell

Gynecol Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical risk score predicts suboptimal debulking or a major perioperative complication in patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Caitlin Stashwick, Miriam D Post, Jaime S Arruda, Monique A Spillman, Kian Behbakht

Int J Gynecol Cancer· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis